Back
ESC Premium Access

Efficacy and safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation and cancer

Session: Prevention of thromboembolism and atrial remodelling in atrial fibrillation
Topic: Oral Anticoagulation
Speaker: Doctor I. Cavallari (Rome, IT)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Ilaria Cavallari

University Campus Bio-Medico of Rome, Rome (Italy)
1 presentation
0 follower

8 more presentations in this session

Equally high detection rates of atrial fibrillation in patients after a TIA and stroke by systematic ECG monitoring with an implanted device: SPIDER-AF study

Speaker: Doctor F. Goss (Munich, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Non valvular atrial fibrillation, contraindication to anticoagulation or antiplatelet therapy and heart team approach: a single centre experience

Speaker: Doctor A. Graffigna (Trento, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Effectiveness and safety of apixaban, dabigatran and warfarin compared to rivaroxaban in non-valvular atrial fibrillation; a Norwegian nationwide cohort study

Speaker: Doctor O. Rutherford (Sarpsborg, NO)

Access
Abstract
Slides
Video
Like
Thumbnail

Non-vitamin K antagonist oral anticoagulants are safe and effective alternatives to warfarin across subgroups by renal function: results from Danish registries

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Access
Abstract
Like
Thumbnail

High mortality in atrial fibrillation patients suffering ischemic stroke, intracranial hemorrhage or a gastrointestinal bleed and associations with the preceding antithrombotic treatment

Speaker: Professor P. Hjemdahl (Stockholm, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Prevention of thromboembolism and atrial remodelling in atrial fibrillation

Speakers: Doctor I. Cavallari, Doctor F. Goss, Doctor A. Graffigna, Doctor O. Rutherford, Doctor A. Nissen Bonde...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources